A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes

по Oliva, Esther N, Schey, Carina, Hutchings, Adam S
Опубликовано 2011

Costs and quality of life in patients with myelodysplastic syndromes

по Lucioni, Carlo, Finelli, Carlo, Mazzi, Silvio, Oliva, Esther N
Опубликовано 2013

Prospective changes of cardiac iron and function in low and intermediate-1 risk mds patients

по Pepe, Alessia, Meloni, Antonella, Carulli, Giovanni, Oliva, Esther N, Arcioni, Francesco, Storti, Sergio, Neri, Mari Giovanna, Grassedonio, Emanuele, Renne, Stefania, Restaino, Gennaro, Positano, Vincenzo, Rizzo, Michele
Опубликовано в: J Cardiovasc Magn Reson (2015)

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians

по Oliva, Esther N., Nobile, Francesco, Alimena, Giuliana, Ronco, Francesca, Specchia, Giorgina, Impera, Stefana, Breccia, Massimo, Vincelli, Iolanda, Carmosino, Ida, Guglielmo, Patrizia, Pastore, Domenico, Alati, Caterina, Latagliata, Roberto
Опубликовано 2011

Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome

по Caracciolo, Massimo, Macheda, Sebastiano, Labate, Demetrio, Tescione, Marco, La Scala, Stefano, Vadalà, Eugenio, Squillaci, Rosalba, D’Aleo, Francesco, Morabito, Antonella, Garreffa, Cristina, Marciano, Maria Concetta, Oliva, Esther N.
Опубликовано в: Front Immunol (2020)

A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes

по Fang, Jing, Liu, Xiaona, Bolanos, Lyndsey, Barker, Brenden, Rigolino, Carmela, Cortelezzi, Agostino, Oliva, Esther N, Cuzzola, Maria, Grimes, H Leighton, Fontanillo, Celia, Komurov, Kakajan, MacBeth, Kyle, Starczynowski, Daniel T
Опубликовано в: Nat Med (2016)

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

по Fang, Jing, Rhyasen, Garrett, Bolanos, Lyndsey, Rasch, Christopher, Varney, Melinda, Wunderlich, Mark, Goyama, Susumu, Jansen, Gerrit, Cloos, Jacqueline, Rigolino, Carmela, Cortelezzi, Agostino, Mulloy, James C., Oliva, Esther N., Cuzzola, Maria, Starczynowski, Daniel T.
Опубликовано 2012

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

по Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Salek, Sam
Опубликовано в: Front Pharmacol (2020)

Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study

по Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Salek, Sam
Опубликовано в: Ther Adv Hematol (2020)

Outcome of therapy-related myeloid neoplasms treated with azacitidine

по Fianchi Luana, Criscuolo Marianna, Lunghi Monia, Gaidano Gianluca, Breccia Massimo, Levis Alessandro, Finelli Carlo, Santini Valeria, Musto Pellegrino, Oliva Esther N, Leoni Pietro, Spiriti Antonietta, D’Alò Francesco, Hohaus Stefan, Pagano Livio, Leone Giuseppe, Voso Maria
Опубликовано 2012-08-01

Outcome of therapy-related myeloid neoplasms treated with azacitidine

по Fianchi, Luana, Criscuolo, Marianna, Lunghi, Monia, Gaidano, Gianluca, Breccia, Massimo, Levis, Alessandro, Finelli, Carlo, Santini, Valeria, Musto, Pellegrino, Oliva, Esther N, Leoni, Pietro, Aloe Spiriti, Antonietta, D’Alò, Francesco, Hohaus, Stefan, Pagano, Livio, Leone, Giuseppe, Voso, Maria Teresa
Опубликовано 2012

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study

по Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Al-Obaidi, Magda J., Oblak, Metod, Salek, Sam
Опубликовано в: Front Pharmacol (2020)

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO

по Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Al-Obaidi, Magda J., Oblak, Metod, Salek, Sam
Опубликовано в: Front Pharmacol (2020)

Early lenalidomide treatment for low and intermediate‐1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence

по Oliva, Esther N., Lauseker, Michael, Aloe Spiriti, Maria Antonietta, Poloni, Antonella, Cortelezzi, Agostino, Palumbo, Giuseppe A., Balleari, Enrico, Sanpaolo, Grazia, Volpe, Antonio, Ricco, Alessandra, Ronco, Francesca, Alati, Caterina, D'Errigo, Maria Grazia, Santacaterina, Irene, Kündgen, Andrea, Germing, Ulrich, Latagliata, Roberto
Опубликовано в: Cancer Med (2015)

Targeting IRAK1 as a therapeutic approach for Myelodysplastic Syndrome

по Rhyasen, Garrett W., Bolanos, Lyndsey, Fang, Jing, Jerez, Andres, Wunderlich, Mark, Rigolino, Carmela, Mathews, Lesley, Ferrer, Marc, Southall, Noel, Guha, Rajarshi, Keller, Jonathan, Thomas, Craig, Beverly, Levi J., Cortelezzi, Agostino, Oliva, Esther N., Cuzzola, Maria, Maciejewski, Jaroslaw P., Mulloy, James C., Starczynowski, Daniel T.
Опубликовано 2013